Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
α-2b interferon for pediatric herpetic pharyngitis (aerosol inhalation)
ChiCTR2400089394Phase 4Not yet recruiting
- Sponsor
- Shifang People's Hospital
- Start
- Sep 2024
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of interferon alfa-2b in herpetic pharyngitis (2 arms), sponsored by Shifang People's Hospital. Primary endpoints: Interleukin-6 (IL-6), Interleukin-10 (IL-10) and 3 more. Planned start Sep 2024; status: not yet recruiting.
02
Drugs
interferon alfa-2b
03
Conditions
herpetic pharyngitis
Beyond the preview
Go deeper on ChiCTR2400089394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400089394.